English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
Loans
Loans
you are here:

Baroda BNP Paribas Health and Wellness Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : Baroda Pioneer Mutual Fund
  • NAV
    : ₹ 9.9077 0.49%
    (as on 19th September, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Fund Size
: ₹ 637.36 Cr
(0.13% of Investment in Category)
 Expense Ratio
: 2.28%
(2.12% Category average)
Risk-O-Meter
Very High Risk

The fund has 94.16% investment in domestic equities of which 31.32% is in Large Cap stocks, 16.84% is in Mid Cap stocks, 12.95% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
₹
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 19th September, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 12-Sep-25 10080.00 0.80% - 1.37% 198/239
1 Month 19-Aug-25 10027.50 0.27% - 2.27% 214/237
Since Inception 27-Jun-25 9907.70 -0.92% -3.95% 13.03% 208/218
Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 19th September, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
No Data Found
SIP Calculator Detailed Returns Analysis
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 5.00%  |   Category average turnover ratio is 154.05%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 94.16% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 94.16%
No of Stocks : 28 (Category Avg - 44.44) | Large Cap Investments : 31.32%| Mid Cap Investments : 16.84% | Small Cap Investments : 12.95% | Other : 33.05%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 797.3 12.51% 0.42% 12.51% (Aug 2025) 0% (Sep 2024) 5.00 L 25.00 k
Divis Laboratories Ltd. Pharmaceuticals 459.9 7.22% 1.32% 7.22% (Aug 2025) 0% (Sep 2024) 75.00 k 15.00 k
Apollo Hospitals Enterprises Ltd. Hospital 380.5 5.97% 0.38% 5.97% (Aug 2025) 0% (Sep 2024) 50.00 k 0.00
Mankind Pharma Ltd. Pharmaceuticals 370.7 5.82% 0.31% 5.82% (Aug 2025) 0% (Sep 2024) 1.50 L 6.16 k
Cipla Ltd. Pharmaceuticals 353.6 5.55% 0.39% 5.55% (Aug 2025) 0% (Sep 2024) 2.23 L 0.00
Max Healthcare Institute Ltd. Hospital 311.7 4.89% 0.11% 4.89% (Aug 2025) 0% (Sep 2024) 2.70 L 13.00 k
Aster DM Healthcare Ltd. Hospital 228.4 3.58% 0.15% 3.58% (Aug 2025) 0% (Sep 2024) 3.80 L 0.00
Abbott India Ltd. Pharmaceuticals 220.4 3.46% -0.13% 3.59% (Jul 2025) 0% (Sep 2024) 7.00 k 0.00
- Torrent Pharmaceuticals Ltd. Pharmaceuticals 208.3 3.27% 0.00% 3.27% (Aug 2025) 0% (Sep 2024) 58.50 k 0.00
Ajanta Pharma Limited Pharmaceuticals 184.2 2.89% -0.16% 3.05% (Jul 2025) 0% (Sep 2024) 74.35 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Detailed Portfolio Analysis
Name Type of Instrument Weight (%)
TREPS TREPS 6.06%
Net Receivables Net Receivables -0.22%
Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

    No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 389.09 11.12 30.65 54.87 46.98 33.53
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 249.75 3.99 11.91 17.77 26.31 18.55
Franklin Asian Equity Fund - Growth NA 259.99 5.92 13.00 16.09 18.21 12.73
Motilal Oswal Business Cycle Fund - Regular Plan - Growth NA 1976.19 4.99 9.24 15.05 17.81 0.00
Nippon India Japan Equity Fund - Growth NA 283.56 1.67 10.25 13.77 16.38 17.74
Nippon India US Equity Opportunities Fund - Growth NA 713.51 3.56 7.49 10.70 15.32 19.93
Motilal Oswal Manufacturing Fund - Regular Plan - Growth NA 786.43 7.55 9.77 22.45 11.37 0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1533.43 6.37 21.68 34.77 11.35 0.00
HDFC Pharma and Healthcare Fund - Regular Plan - Growth NA 1909.30 1.54 8.60 11.90 10.56 0.00
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8370.76 0.28 2.83 15.38 10.43 17.86

More Funds from Baroda Pioneer Mutual Fund

Out of 53 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 2 is/are ranked 4 * , 8 is/are ranked 3 * , 5 is/are ranked 2 * , 2 is/are ranked 1 * , and 34 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Baroda BNP Paribas Liquid Fund - Regular Plan - Growth 3 10107.81 0.46 1.41 3.22 6.77 6.96
Baroda BNP Paribas Balanced Advantage Fund - Growth NA 4331.79 1.24 2.21 10.54 3.51 14.19
Baroda BNP Paribas Balanced Advantage Fund - Growth NA 4331.79 1.24 2.21 10.54 3.51 14.19
Baroda BNP Paribas Multi Cap Fund - Regular Plan - Growth 3 2923.05 2.22 4.84 12.64 -1.41 19.48
Baroda BNP Paribas Large Cap Fund - Regular Plan - Growth 3 2646.18 0.98 2.29 10.11 -3.59 16.17
Baroda BNP Paribas Money Market Fund - Growth 2 2306.06 0.49 1.54 4.01 7.70 7.15
Baroda BNP Paribas Mid Cap Fund - Regular Plan - Growth 3 2157.05 1.51 3.84 13.00 -2.45 19.25
Baroda BNP Paribas Ultra Short Duration Fund - Growth 4 1614.95 0.48 1.51 3.74 7.40 7.27
Baroda BNP Paribas Large and Mid Cap Fund - Regular Plan - Growth 3 1599.63 1.06 1.89 10.50 -5.10 18.18
Baroda BNP Paribas India Consumption Fund - Growth NA 1512.04 3.13 8.15 13.62 -4.00 16.33
All funds

Forum

POST

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347